In Depth 18 Jul 2025
Hyderabad’s Genome Valley, biopharma’s scale-up hub
Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and gene therapy.
Partnerships
- Latest Posts
News and Trends 15 Jul 2025
Serial acquirer Concentra Biosciences on a buyout spree in 2025
Concentra Biosciences is buying struggling biotechs and its portfolio has been growing rapidly in 2025. Learn about what it has been up to this past year.
News and Trends 11 Jul 2025
XOMA Royalty’s acquisition of Turnstone Biologics: what do royalty deals offer the biopharma industry?
Turnstone Biologics is being acquired by royalty aggregator Xoma Royalty. Discover how royalty deals are shaping the biopharma industry.
In Depth 7 Jul 2025
Biotech in Vienna: a budding life science hub
As biotech in Vienna raked in €22.7 billion in 2023, there has been a significant increase in innovation, research, and employment in recent years.
Best in Biotech 4 Jul 2025
14 biotech companies to know in the Boston area in 2025
Explore Boston’s vibrant biotech landscape with fourteen innovative companies leading the charge in life sciences research.
News and Trends 2 Jul 2025
Top biotech deals in June 2025
Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and immunotherapies.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 30 Jun 2025
Life sciences in Wales: biotechs in the scene in 2025
As biotech startups navigate the growing biotech sector in Wales, here are five biotech companies that are making waves in 2025.
Podcast 20 Jun 2025
Special Episode: The 2025 BIO International Convention
In this week’s episode we meet three innovators on the floor in Boston and find out what their BIO experience has been like
In Depth 18 Jun 2025
From undruggable to oral therapy: The rise of STAT6 degraders
Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment.
News and Trends 11 Jun 2025
Behind the Cure51 deal: Is NVIDIA becoming biotech’s AI infrastructure?
On the occasion of its deal with Cure51, find out about NVIDIA’s biotech strategy as it gets more and more involved in the industry.
News and Trends 2 Jun 2025
Top biotech deals in May 2025
Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and antibodies.
In Depth 28 May 2025
New weight loss drugs: Biotech’s mission to end obesity
Find out more about biotech’s mission to end obesity, as we look at the new weight loss drugs that are in development.
ADVERTISEMENT
